DOACs have bleeding risk comparable to warfarin

A new type of drug used to treat blood clots does not put patients at a higher bleeding risk than warfarin, researchers have found Recent trials have shown similar effectiveness and a reduced or similar risk of major bleeding complications for DOACs compared with warfarin, the authors of the new study say. However, clinical trials